Address
Other Office
21 Waterway Avenue,
Suite 225
The Woodlands, TX 77380
United States
Phone
Website
Recent investment activity
KANDO id: 30232
Corporate information
Registration country
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 76 - 100 of 104| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Velcera Inc | N/A | ||||
|
|
Victory Pharma Inc | Specialty pharmaceutical company | N/A | |||
|
|
White Pine Medical | Targets medical device growth equity acquisitions | N/A | |||
|
|
Xanodyne Pharmaceuticals Inc | Specialty pharmaceuticals for pain and women's health | N/A | |||
|
|
Ziopharm Oncology Inc | Biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs. | N/A | |||
|
Accumetrics Inc | Innovative developer and manufacturer of diagnostic instrumentation and test kits. | Venture | |||
|
|
Accumetrics Inc | Innovative developer and manufacturer of diagnostic instrumentation and test kits. | Series E | |||
|
|
Accumetrics Inc | Innovative developer and manufacturer of diagnostic instrumentation and test kits. | Series D | |||
|
|
Accumetrics Inc | Innovative developer and manufacturer of diagnostic instrumentation and test kits. | Series C | |||
|
|
Accumetrics Inc | Innovative developer and manufacturer of diagnostic instrumentation and test kits. | Series B | |||
|
|
Active Day Inc | Provider of adult day health services in the United States. | N/A | |||
|
|
Acura Pharmaceuticals | Pharmaceutical company | N/A | |||
|
|
Allscripts Healthcare Solutions Inc | N/A | ||||
|
|
Arsenal Medical Inc | Biotechnology company focused on the development of therapeutic products based on its proprietary BioActive Composites platform. | N/A | |||
|
|
BreatheAmerica Inc | N/A | ||||
|
|
Cell Therapeutics Inc | Biotherapeutics for cancer treatment. | N/A | |||
|
|
Chroma Therapeutics Ltd | Focused on harnessing the power of chromatin biology and novel drug accumulation approaches to discover and develop a new generation of targeted cance | N/A | |||
|
Complete Genomics Inc | Series E | ||||
|
|
Complete Genomics Inc | Series D | ||||
|
Entellus Medical Inc | Developer of innovative device technology and treatment to address the unmet needs of ENT physicians and their patients. | Series E | |||
|
|
Entellus Medical Inc | Developer of innovative device technology and treatment to address the unmet needs of ENT physicians and their patients. | Series D | |||
|
|
Kona Medical Inc | Developer of non-invasive treatment for hypertension | Series C | |||
|
|
NeoVista Inc | Series E Follow-on investment | ||||
|
|
NeoVista Inc | Series D Follow-on investment | ||||
|
|
NeoVista Inc | Series C Initial investment |